Medical Tourism
ARISTOLOFT, is supporting new alternative treatments by helping interested clients with unmet medical needs to review together with a team of medical specialist the possibility of therapies to improve the quality of life. Basically, with our concept we help the body to restore, regenerate itself by increasing the natural capability of the body to heal itself with highly reputed international partners.
Unfortunately, new science-based technics are very slowly adopted and incorporated into existing health related regulations, this, and often lower prices have resulted that patients willing to pay for improving their quality of life, started to look outside their home country where such therapies are not yet available.
This “phenomena” is called Medical tourism and can be defined best as the process of traveling outside the country of residence for the purpose of receiving medical care, either not available in the country of residence or at much lower prices, justifying the travel to a foreign country.
As partner of international organizations, we are able to providing patients with qualified holistic and cellular treatment to support their unmet medical need. Procedures we are suggesting in this website are investigational, and based on electromagnetic pulsed therapy, combined with low level laser therapy and the regeneration of cellular structure with supplements and with mesenchymal stem cells based on protocols from an Institutional Reviewing Boards (IRB) and / or Ethical committees in countries where such a treatment is permitted, as well as nutritional supplements supporting cellular and especially telomeres health.
Stem cell therapies are in general not approved in Western Countries, except, they are based on supportive clinical trials and the relevant FDA / EMA approval.
In July, 2022, the USA registered 1121 clinical trials with mesenchymal stem cells alone, (https://www.clinicaltrials.gov), where institutes, hospitals or clinics performing stem cell therapies as a registered investigational procedure. Only very few products had been so far approved and patented by the pharmaceutical industry via this clinical pathway, and even if, often those products are accompanied by a very high price tags, making it very difficult to be supported by insurance and healthcare organizations.
Over the last decade, only 15 advanced therapy medicinal products (ATMPs) – that refers to, stem cell and gene therapies – have received approval in Europe. With four withdrawals, only 11 of them (2022) still have a valid marketing authorization. That is a stark contrast with the fact that there have been over 500 clinical trials using ATMPs in the EU alone, since 2009. ATMPs are, according to EMA, advanced therapy medicinal products, i.e. all those new medicinal products based on stem cell and gene therapy following the clinical trial path in order to be approved as evidence based medicine.
The drug, Glybera, as an example, was the most expensive prescription medication in history at $1 million for a one-time round of injections and was withdrawn by the manufacture due to a commercial flop.
Strimvelis, is treating an ultra-rare immune deficiency, has a list price of 594,000 Euros, making it one of the most expensive drugs available, and had been sold so far only a few times, becoming also not a viable product in respect of commercialization, as drugs deriving by this clinical pathway as evidence based medicine are designed to be sold as patented remedy to the mass market at affordable prices.
This situation has encouraged stem cell clinics all over the world even further, to help patients with unmet medical needs by using the concept of a medical procedure, and not the complex, and highly manipulated cell therapy approved drug pathway, which is mandatory for all kind of drugs, including own stem cells, according to the industry and regulatory authorities.
Several countries in the world have, in recent years, provided new legislation which allows cellular therapy with mesenchymal stem cells as a medical procedure, where the patient, and the doctor performing the procedure are signing an informed consent, allowing a patient funded therapy. Such a therapy usually costs between 6.000 and 25.000 USD, and appears not only more affordable but also safe with anecdotal success statements.
Millions of treatments had been performed on this basis in thousands of stem cell clinics, all over the world including the USA, and Europe, although the regulatory agencies, like the FDA and EMA are developing new regulations to try stopping such medical procedures in favour of patented drugs. Only a few cases with serious side effects (AE), with stem cells as a medical procedure are reported, because of a medical doctor´s wrong procedure, are known and blown out of proportion by the industry and regulatory authorities to stop this easy medical and economic viable alternative to improve quality of life.
Comparing this few cases with the official government statistics of serious side effects, recorded as adverse event (AE) reaching more than hundred thousand death per year with approved medical drugs, the attempt to stop a medical procedure with stem cells as an example, appears somehow not justified even from a safety point of view. Besides this, pharmaceutical drugs are industrialized produced products for the mass market, with the potential risk that individual cases are harmed, whereas the medical procedure is a singular event, performed by a doctor, with a written consent of the patient, being a one-time personalized medical activity to improve quality of life in a singular case.
An adverse event (AE) is defined as an injury caused by an approved pharmaceutical drug and is representing the 4th leading cause of death in the USA, after heart disease, cancer and stroke, but well ahead of diabetes, pulmonary diseases and AIDS.
Source: https://www.nature.com/articles/s41598-019-56525-5
Clients, being interested to experience stem cell therapy as a medical procedure, need to contact us and follow our internal protocol before being accepted for such a therapy in a country where stem cell therapy is legalized.
Unfortunately, new science-based technics are very slowly adopted and incorporated into existing health related regulations, this, and often lower prices have resulted that patients willing to pay for improving their quality of life, started to look outside their home country where such therapies are not yet available.
This “phenomena” is called Medical tourism and can be defined best as the process of traveling outside the country of residence for the purpose of receiving medical care, either not available in the country of residence or at much lower prices, justifying the travel to a foreign country.
As partner of international organizations, we are able to providing patients with qualified holistic and cellular treatment to support their unmet medical need. Procedures we are suggesting in this website are investigational, and based on electromagnetic pulsed therapy, combined with low level laser therapy and the regeneration of cellular structure with supplements and with mesenchymal stem cells based on protocols from an Institutional Reviewing Boards (IRB) and / or Ethical committees in countries where such a treatment is permitted, as well as nutritional supplements supporting cellular and especially telomeres health.
Stem cell therapies are in general not approved in Western Countries, except, they are based on supportive clinical trials and the relevant FDA / EMA approval.
In July, 2022, the USA registered 1121 clinical trials with mesenchymal stem cells alone, (https://www.clinicaltrials.gov), where institutes, hospitals or clinics performing stem cell therapies as a registered investigational procedure. Only very few products had been so far approved and patented by the pharmaceutical industry via this clinical pathway, and even if, often those products are accompanied by a very high price tags, making it very difficult to be supported by insurance and healthcare organizations.
Over the last decade, only 15 advanced therapy medicinal products (ATMPs) – that refers to, stem cell and gene therapies – have received approval in Europe. With four withdrawals, only 11 of them (2022) still have a valid marketing authorization. That is a stark contrast with the fact that there have been over 500 clinical trials using ATMPs in the EU alone, since 2009. ATMPs are, according to EMA, advanced therapy medicinal products, i.e. all those new medicinal products based on stem cell and gene therapy following the clinical trial path in order to be approved as evidence based medicine.
The drug, Glybera, as an example, was the most expensive prescription medication in history at $1 million for a one-time round of injections and was withdrawn by the manufacture due to a commercial flop.
Strimvelis, is treating an ultra-rare immune deficiency, has a list price of 594,000 Euros, making it one of the most expensive drugs available, and had been sold so far only a few times, becoming also not a viable product in respect of commercialization, as drugs deriving by this clinical pathway as evidence based medicine are designed to be sold as patented remedy to the mass market at affordable prices.
This situation has encouraged stem cell clinics all over the world even further, to help patients with unmet medical needs by using the concept of a medical procedure, and not the complex, and highly manipulated cell therapy approved drug pathway, which is mandatory for all kind of drugs, including own stem cells, according to the industry and regulatory authorities.
Several countries in the world have, in recent years, provided new legislation which allows cellular therapy with mesenchymal stem cells as a medical procedure, where the patient, and the doctor performing the procedure are signing an informed consent, allowing a patient funded therapy. Such a therapy usually costs between 6.000 and 25.000 USD, and appears not only more affordable but also safe with anecdotal success statements.
Millions of treatments had been performed on this basis in thousands of stem cell clinics, all over the world including the USA, and Europe, although the regulatory agencies, like the FDA and EMA are developing new regulations to try stopping such medical procedures in favour of patented drugs. Only a few cases with serious side effects (AE), with stem cells as a medical procedure are reported, because of a medical doctor´s wrong procedure, are known and blown out of proportion by the industry and regulatory authorities to stop this easy medical and economic viable alternative to improve quality of life.
Comparing this few cases with the official government statistics of serious side effects, recorded as adverse event (AE) reaching more than hundred thousand death per year with approved medical drugs, the attempt to stop a medical procedure with stem cells as an example, appears somehow not justified even from a safety point of view. Besides this, pharmaceutical drugs are industrialized produced products for the mass market, with the potential risk that individual cases are harmed, whereas the medical procedure is a singular event, performed by a doctor, with a written consent of the patient, being a one-time personalized medical activity to improve quality of life in a singular case.
An adverse event (AE) is defined as an injury caused by an approved pharmaceutical drug and is representing the 4th leading cause of death in the USA, after heart disease, cancer and stroke, but well ahead of diabetes, pulmonary diseases and AIDS.
Source: https://www.nature.com/articles/s41598-019-56525-5
Clients, being interested to experience stem cell therapy as a medical procedure, need to contact us and follow our internal protocol before being accepted for such a therapy in a country where stem cell therapy is legalized.
Steps to review
whether, a patient may be eligible for a treatment or not
The first step is the submission of the persons profile with details of his / her present health situation by Email.
This information shall include, the actual report of a medical doctor describing existing conditions and sofar used method to improve the condition. This report should be acompanied by X-Rays, MRIs, general and specific blood tests, actual treatments results, medication taken and how long as well as a Pain scale review where needed.
In some cases, we may ask for additional specific analysis data, especially bioenergetic health screeing to potentially detect the root cause of a condition.
The second step of the “Review of the condition to be treated" is to conduct a Zoom / WhatsApp call. During such a 30 minute free session, in English Language by the representative of the clinic / the medical team, methods to potentially improvement of the quality of life are discussed.
During this session we also will provide detailed information about the investigational character of the treatment as a medical procedure, which requires a written consent of the patient and the medical doctor performing the procedure as well estimated costs of the procedure. Please note that with any medical procedure the expected outcome is not guaranteed.
Medical procedures are not approved by regulatory authorities like FDA in the US or EMA in Europe, while ongoing discussions with health authorities have resulted that various countries have made a legal framework, accepting cellular, and stem cell therapy as a medical procedure. Our cellular and stem cell therapy treatments, therefore, are performed only in countries having legalized such procedures, that means you most likely have to travel by plane to such destinations. Furthermore, those procedures, beside being performed in a legalized clinic, are performed on the basis of an IRB approved protocol like e.g. at Cell Surgical Network, California.
In the event the treatment is accepted by the client as well as the medical team, as a medical procedure in the frame of a patient-funded investigational therapy and its cost, we will review when the treatment can be performed.
After coordinating the time schedules of the performing physician and the client visit, we will confirm the treatment, with the exact day and time, and the final treatment cost. With the confirmation of the treatment date, 25 percent of the total costs are due, while the remainder is payable latest 10 days in full, before the agreed treatment date. In case the client will cancel the treatment for any reason, after the treatment is confirmed and accepted by both parties, the 25 % downpayment of the total cost due, after signing the agreement, is lost. Reason for this is, the clinic has to plan and prepare the technical space for the operation as well as the availability of the medical doctor, technicians and nurses to perform the procedure. In case of a "no show" this are cost of the scheduled operation which have to be covered by the patient, or his legal representative.
Please note that our medical partners are well booked and unfortunately do not agree on any refund policy. In case of force major however, well documented including the actual medical status, our clinic partners are prepared, to potentially schedule a new treatment date which requires the same payment procedure as mentioned above.
If requested, we also assist to review flights, assist with potential Visa application if needed, as well the hotel selection and recommendation during the treatment stay in the country where the treatment is performed. For further details please contact us.
This information shall include, the actual report of a medical doctor describing existing conditions and sofar used method to improve the condition. This report should be acompanied by X-Rays, MRIs, general and specific blood tests, actual treatments results, medication taken and how long as well as a Pain scale review where needed.
In some cases, we may ask for additional specific analysis data, especially bioenergetic health screeing to potentially detect the root cause of a condition.
The second step of the “Review of the condition to be treated" is to conduct a Zoom / WhatsApp call. During such a 30 minute free session, in English Language by the representative of the clinic / the medical team, methods to potentially improvement of the quality of life are discussed.
During this session we also will provide detailed information about the investigational character of the treatment as a medical procedure, which requires a written consent of the patient and the medical doctor performing the procedure as well estimated costs of the procedure. Please note that with any medical procedure the expected outcome is not guaranteed.
Medical procedures are not approved by regulatory authorities like FDA in the US or EMA in Europe, while ongoing discussions with health authorities have resulted that various countries have made a legal framework, accepting cellular, and stem cell therapy as a medical procedure. Our cellular and stem cell therapy treatments, therefore, are performed only in countries having legalized such procedures, that means you most likely have to travel by plane to such destinations. Furthermore, those procedures, beside being performed in a legalized clinic, are performed on the basis of an IRB approved protocol like e.g. at Cell Surgical Network, California.
In the event the treatment is accepted by the client as well as the medical team, as a medical procedure in the frame of a patient-funded investigational therapy and its cost, we will review when the treatment can be performed.
After coordinating the time schedules of the performing physician and the client visit, we will confirm the treatment, with the exact day and time, and the final treatment cost. With the confirmation of the treatment date, 25 percent of the total costs are due, while the remainder is payable latest 10 days in full, before the agreed treatment date. In case the client will cancel the treatment for any reason, after the treatment is confirmed and accepted by both parties, the 25 % downpayment of the total cost due, after signing the agreement, is lost. Reason for this is, the clinic has to plan and prepare the technical space for the operation as well as the availability of the medical doctor, technicians and nurses to perform the procedure. In case of a "no show" this are cost of the scheduled operation which have to be covered by the patient, or his legal representative.
Please note that our medical partners are well booked and unfortunately do not agree on any refund policy. In case of force major however, well documented including the actual medical status, our clinic partners are prepared, to potentially schedule a new treatment date which requires the same payment procedure as mentioned above.
If requested, we also assist to review flights, assist with potential Visa application if needed, as well the hotel selection and recommendation during the treatment stay in the country where the treatment is performed. For further details please contact us.
General information about basic treatment techniques
In case of autologous treatments, we, our partners, use a minimally invasive surgical technique conducted right in the clinic. Stem cells can be harvested either from bone marrow or adipose tissue. In case of adipose tissues, stem cells are extracted via a mini-liposuction (local anesthesia). This mixture, the so-called Stromal Vascular Fraction (SVF) is then processed and returned to the same body within hours. Those cells can however also be expanded and cryopreserved for additional later treatment needs.
Bone marrow fluid (aspirate) and tissue sample (biopsy) are usually collected from the top ridge of the back of a hipbone (posterior iliac crest). There are two types of bone marrow: red and yellow. Red marrow contains blood stem cells that can become red blood cells, white blood cells, or platelets. Yellow marrow is made mostly of fat and contain MSCs. Those cells can also be expanded and cryopreserved for additional later treatment needs.
Allogeneic therapies are based on expanded Mesenchymal stem cells from highly qualified and medical processed umbilical cord tissue / Wharton Jelly. Those MSCs have shown interesting results from Autism to antiaging and regeneration in general.
Basically, we help the patient´s body to restore, regenerate itself by isolating stem cells from one location of the body to the area of disease, injury or inflammation or with allogeneic and expanded stem cells to increase the body's stem cell population and to improve its natural regenerative capability. The natural capability to heal and repair damaged tissues are hampered over time as the quantity and quality of stem cells in a human body deteriorate, which is considered by new science insights as stem cell exhaustion. This situation can be improved by injecting new stem cells to increase the stem cell population and the ability to repair, heal, regenerate the body.
Standard Treatment with autologous, own stem cells, or allogeneic stem cells will take about 3 to 4 hours, with the full assistance of medically qualified staff. Cells may, as mentioned before, be collected via a mini liposuction, a bone marrow puncture or provided from cord blood tissues and delivered at a site specific area, e.g. a joint injection, an IV, intrathecally or intramuscularly. Physicians of the clinic are trained, experient and committed to making the process as comfortable as possible.
Which method will or better should be applied depends on the medical condition as well as the regulation of a country. The USA regulates stem cell therapies different than Costa Rica or China, India and Europe. As mentioned before we are only performing stem cell therapies in countries where it is legally permitted. This means for most potential clients you will have to take a flight to such destinations.
In case of autologous treatments, we, our partners, use a minimally invasive surgical technique conducted right in the clinic. Stem cells can be harvested either from bone marrow or adipose tissue. In case of adipose tissues, stem cells are extracted via a mini-liposuction (local anesthesia). This mixture, the so-called Stromal Vascular Fraction (SVF) is then processed and returned to the same body within hours. Those cells can however also be expanded and cryopreserved for additional later treatment needs.
Bone marrow fluid (aspirate) and tissue sample (biopsy) are usually collected from the top ridge of the back of a hipbone (posterior iliac crest). There are two types of bone marrow: red and yellow. Red marrow contains blood stem cells that can become red blood cells, white blood cells, or platelets. Yellow marrow is made mostly of fat and contain MSCs. Those cells can also be expanded and cryopreserved for additional later treatment needs.
Allogeneic therapies are based on expanded Mesenchymal stem cells from highly qualified and medical processed umbilical cord tissue / Wharton Jelly. Those MSCs have shown interesting results from Autism to antiaging and regeneration in general.
Basically, we help the patient´s body to restore, regenerate itself by isolating stem cells from one location of the body to the area of disease, injury or inflammation or with allogeneic and expanded stem cells to increase the body's stem cell population and to improve its natural regenerative capability. The natural capability to heal and repair damaged tissues are hampered over time as the quantity and quality of stem cells in a human body deteriorate, which is considered by new science insights as stem cell exhaustion. This situation can be improved by injecting new stem cells to increase the stem cell population and the ability to repair, heal, regenerate the body.
Standard Treatment with autologous, own stem cells, or allogeneic stem cells will take about 3 to 4 hours, with the full assistance of medically qualified staff. Cells may, as mentioned before, be collected via a mini liposuction, a bone marrow puncture or provided from cord blood tissues and delivered at a site specific area, e.g. a joint injection, an IV, intrathecally or intramuscularly. Physicians of the clinic are trained, experient and committed to making the process as comfortable as possible.
Which method will or better should be applied depends on the medical condition as well as the regulation of a country. The USA regulates stem cell therapies different than Costa Rica or China, India and Europe. As mentioned before we are only performing stem cell therapies in countries where it is legally permitted. This means for most potential clients you will have to take a flight to such destinations.
Medical Science a fast developing discipline
Technology and scientific breakthroughs are moving us forward in ways we never expected. This ongoing discovery in medical science has given rise to new and alternative methods of treatment, new ways of managing our lives.
Bioenergetic health screeing to find the root cause of ilnesses, energy medicine and regenerative stem cell therapy, to help our body to heal itself naturally, has become one of the most exciting and promising fields of biological and health science today. Advancements in medical science, and in particular in stem cell therapy give us the ability to manage our health with new health maintenance and wellness methods so we can live fuller and healthier lives together with our loved ones.
Bioenergetic health screeing to find the root cause of ilnesses, energy medicine and regenerative stem cell therapy, to help our body to heal itself naturally, has become one of the most exciting and promising fields of biological and health science today. Advancements in medical science, and in particular in stem cell therapy give us the ability to manage our health with new health maintenance and wellness methods so we can live fuller and healthier lives together with our loved ones.
Words like regeneration technologies, antiaging, telomeres and stem cells became buzzwords in health maintenace in the end of last century, inspiring, however, our mind to start investigating and applying alternative treatments in medicine.
Regulators, however, very quickly, and unfortunately, entered this field with a lot of red tape in the name of patient safety and a battles of how to implement this alternative medicine started, giving countries, who adopted to new technologies faster with an attractive price, an edge in the health care therapy, and with it so-called medical tourism developed quickly.
Unfortunately, like in many early advancements in the field of life science and business, some doctors, clinics used this new method of treating health without having the right equipment nor technology and know how, resulting even in a few adverse events with such treatments, being used as negative examples, which prompted regulators even more quickly to enter the activity with red taps and outdated, but fast to implement regulations in the name of safety of patients.
Regulators, however, very quickly, and unfortunately, entered this field with a lot of red tape in the name of patient safety and a battles of how to implement this alternative medicine started, giving countries, who adopted to new technologies faster with an attractive price, an edge in the health care therapy, and with it so-called medical tourism developed quickly.
Unfortunately, like in many early advancements in the field of life science and business, some doctors, clinics used this new method of treating health without having the right equipment nor technology and know how, resulting even in a few adverse events with such treatments, being used as negative examples, which prompted regulators even more quickly to enter the activity with red taps and outdated, but fast to implement regulations in the name of safety of patients.
Together, we can achieve quickly a better health
Scientist and medical doctors, especially, having basically the same aim. "The honorable aim is to improve quality of life of patients", but it appears both sides are caught up in defending scientific, ethical and commercial point of views more, than to concept of improving quality of Life.
This is neglecting that an open cooperation between scientist and medical doctors as well as regulators to applying new science in the practice of medicine is more important than the defending of a viewpoint based on established regulatory insights of the past which protects more the actual and monetary side of medical products, than patient benefits. Especially when it comes to stem cells, as they are natural products of a persons body, which naturally know how to induce regeneration and healing in a body and should not be a target of the industry for patenting a therapy which naturally occurs .
This is neglecting that an open cooperation between scientist and medical doctors as well as regulators to applying new science in the practice of medicine is more important than the defending of a viewpoint based on established regulatory insights of the past which protects more the actual and monetary side of medical products, than patient benefits. Especially when it comes to stem cells, as they are natural products of a persons body, which naturally know how to induce regeneration and healing in a body and should not be a target of the industry for patenting a therapy which naturally occurs .
|
When looking into this “battlefield”, since 2016, the front of those believing that it is too early to use this alternative medical treatment in humans hardened and applied medical science unfortunately in FDA or EMA regulated countries went either to a kind of underground, claiming that medical procedure cannot be regulated by FDA / EMA, whereas at the same time regulators try to enlarged the definition of what are drugs, by including even autologous stem cell treatments into their “manipulated drug definition”, which results that any product before being used at humans has to follow the stringent clinical trial path, which cost according to latest estimations about 2,6 billion USD and takes about 15 years before a product potentially is approved.
|
The hope, about 20 years ago, that stem cell treatment would become quickly mainstream, did not materialize due to fact that authorities made regulations, which did not adapt to a new reality but even increased barriers to defend the existing pathway to develop pharmaceutical products via clinical trials to become eventually evidenced based medicine.
Governments taking action for a better health
In last few year´s various governments, especially those in Asian Countries, like Japan, but also Australia, and Latin and Central American countries started to adjust their existing regulation, valid for heavily manipulated chemical and biological products, to the new field of regenerative medicine. Panama, Costa Rica, Mexico and the Bahamas declared this medical field even as an important income source in the growing medical tourism industry, but also gives hope for the future of humanity as those new technics, may quickly developing, which eventually may change the present medical treatment from treating symptoms to curing illnesses.
Like everything in life, when it comes to change, especially when leapfrogging and disruptive technologies are involved, we are facing the gravitational war of those trying to maintain the “status quo” against those few advancing quickly towards the next step of evolution.
I remembered in this respect, always the words of the German Philosopher Arthur Schopenhauer (1788-1860), words being certain still true in our 21st century, discribing well the often existing man-made barrier to the success of change, Schopenhauer once said:
“All truth,
maybe today we should rather say all NEW REALITY,
passes through three stages:”
1stFirst, it is ridiculed. |
2ndSecond, it is violently opposed. |
3rdit is accepted as being self-evident. |
This statement fits really well into the thinking pattern of many western minded regulatory authorities when it comes to new scientific advances in medicine, while more open-minded governments support these new treatment opportunities even via medical tourism activities. This situation appears to be a competition of legalized monetary activity contra non legalized but also monetary activity.
The very interesting field of stem cells was apparent and unfortunately politicized by people who used it for their voting tactics claiming they are against embryonic stem cell research as it destroys lives. Truth is, embryonic stem cell research today, as well as in the past, has very little to do with destroying lives, and adult stem cell research and treatment have nothing in common with embryonic stem cell treatment besides the word stem cells. But due to this politicized fact, only a few, less than a handful of products, not even based on embryonic stem cell research, had been approved by the FDA / EMA at prices which do not allow an easy treatment of the masses as the budget of National Health Services cannot afford it. New Stem cell approved drugs costing usually 200 K USD plus. Even one of the approved gene manipulated products, a product for a rare disease, approved in Europe cost 1.0 Million USD per treatment, was accepted once and taken off the market in the meantime as a commercially not viable product....others already followed!
Out of more than 6240 register clinical trials with stem cells and 1120 with specific mesenchymal stem cells only a few had been approved so far. Considering that the medical concept was introduced in the 1990s a few applications made it of becoming an approved medical drug, this indicates that this concept may not be the way forward as an alternative treatment of our aging population and the treatment of chronic diseases. Like to know more details of running clinical trials, please follow link:
https://clinicaltrials.gov/ct2/results?cond=stem+cell&term=&cntry=&state=&city=&dist=&Search=Search
https://clinicaltrials.gov/ct2/results?cond=stem+cell&term=&cntry=&state=&city=&dist=&Search=Search
The potential
to save life’s and to improve quality of life
|
It is a fact, that due to an inadequate approval process, at least for autologous stem cell treatments, the potential to save life’s and to improve quality of life of patients at much lower cost via medical procedures has, in our point of view, blocked the advancement in this field in those regulated countries.
Highly manipulated stem cells and gene therapies certainly may have long-termed negative influence of our cell structure, and need to be specifically regulated, like the chemical and biochemical products. But regulate autologous or allogeneic stem cell treatments, using them basically as they are, knowing that those cells naturally engage in repair and regeneration where needed is like to regulate a spaceship travel activity in the same way as the travel of a cart pulled by a donkey. |
Wrong or right, changes are a part of our technology-driven life environment and those staying in the way of those changes are in the end reducing, at least delaying, the potential to improve quality of life for others at an early stage.
What is furthermore really unpleasant, is that high ranking public figures when it comes to saving, or improve their own quality of life, bypasses these regulations they favor, by visiting those countries allowing this alternative medical treatment already, becoming even a symbol of success of such so-called "unproven and not authorized" therapies. Famous people like Mel Gibson, Beckham, Madonna, Tony Robbins are a few examples having performed stem cell treatments to improve their quality of life, and openly believing in alternative medicine. |
So, what is the alternative we have today when it comes to too much politically motivated regulation in a world without nearly no borders, where people can travel to any place in the world and satisfy their unmet medical need? Well, it is again the privilege of those having money to satisfy this need, and those who are elected by the people to become their government to serve the interest of those people who voted for them are leaving empty-handed.
Progress means change, and change is risky, but like Jim Rohn, one of my favorite mentors once said, life is risky because you are not coming out alive! Therefore, you need to grab the change as a way and opportunity to go forward timely. Any new way may not always be at first, “the optimum” way, but it’s an opportunity to learn, adapt, and improve constantly to be considered as the new approved standard.
Improvement of quality of life never imagined
Quality of life is personal, and regulators do not really comprehend that for a person with COPD e.g., depending already on an oxygen mask to live, a life without it or the capability to walk a longer distance without taking medication with heavy side effects, is an improvement of quality of life never imagined with traditional treatment methods. Those investigational improvements should not be denied to patients in need, just because regulators do not support this progress in the name of overrated and overstated “Patient safety”, which becomes a hidden barrier of applied medical advancements.
Like to know more, please contact us.
Disclaimer:
If you LIKE TO CONTINUE READING PLEASE READ OUR DISCLAIMER. In case you do not want to be bound by the terms of this website, please discontinue reading the educational information provided in this website.
Aristoloft
Like to know more, please contact us.
Disclaimer:
If you LIKE TO CONTINUE READING PLEASE READ OUR DISCLAIMER. In case you do not want to be bound by the terms of this website, please discontinue reading the educational information provided in this website.
Aristoloft
